APO Research
Talk to an analyst

APO RESEARCH · REPORT

Precision Medicine Research and Development Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Precision Medicine Research and Development Platform Market Outlook and Growth Opportunities 2026

5 March 2026192 pages

Choose your research edition.

Industry ResearchPrecision Medicine Research and Development Platform Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Precision Medicine Research and Development Platform Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Precision Medicine Research and Development Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Precision Medicine Research and Development Platform Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Precision Medicine Research and Development Platform Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Precision Medicine Research and Development Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Precision Medicine Research and Development Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Precision Medicine Research and Development Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Precision Medicine Research and Development Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Precision Medicine Research and Development Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Precision Medicine Research and Development Platform market include Engine Biosciences, Illumina, Thermo Fisher Scientific, Qiagen, Personalis, 23andMe and Foundation Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Precision Medicine Research and Development Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Precision Medicine Research and Development Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Precision Medicine Research and Development Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Precision Medicine Research and Development Platform market.

Precision Medicine Research and Development Platform Segment by Company

Engine Biosciences

Illumina

Thermo Fisher Scientific

Qiagen

Personalis

23andMe

Foundation Medicine

Precision Medicine Research and Development Platform Segment by Type

Genomics Platform

Proteomics Platform

Transcriptomics Platform

Others

Precision Medicine Research and Development Platform Segment by Application

Personalized Medicine

Drug Discovery

Precision Medicine Research and Development Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Precision Medicine Research and Development Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Precision Medicine Research and Development Platform key companies, revenue, market share, and recent developments.

3. To split the Precision Medicine Research and Development Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Precision Medicine Research and Development Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Precision Medicine Research and Development Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Precision Medicine Research and Development Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine Research and Development Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine Research and Development Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine Research and Development Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Precision Medicine Research and Development Platform industry.

Chapter 3: Detailed analysis of Precision Medicine Research and Development Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Precision Medicine Research and Development Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Precision Medicine Research and Development Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Precision Medicine Research and Development Platform Industry Trends Table 2. Precision Medicine Research and Development Platform Industry Drivers Table 3. Precision Medicine Research and Development Platform Industry Opportunities and Challenges Table 4. Precision Medicine Research and Development Platform Industry Restraints Table 5. Global Precision Medicine Research and Development Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Precision Medicine Research and Development Platform Revenue Share by Company (2021-2026) Table 7. Global Precision Medicine Research and Development Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Precision Medicine Research and Development Platform Key Company Manufacturing Base & Headquarters Table 9. Global Precision Medicine Research and Development Platform Company, Product Type & Application Table 10. Global Precision Medicine Research and Development Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Precision Medicine Research and Development Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Genomics Platform Table 15. Significant Companies of Proteomics Platform Table 16. Significant Companies of Transcriptomics Platform Table 17. Significant Companies of Others Table 18. Global Precision Medicine Research and Development Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Precision Medicine Research and Development Platform Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Precision Medicine Research and Development Platform Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Precision Medicine Research and Development Platform Sales Value Share by Type (2021-2026) Table 22. Global Precision Medicine Research and Development Platform Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Personalized Medicine Table 24. Significant Companies of Drug Discovery Table 25. Global Precision Medicine Research and Development Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Precision Medicine Research and Development Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Precision Medicine Research and Development Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Precision Medicine Research and Development Platform Sales Value Share by Application (2021-2026) Table 29. Global Precision Medicine Research and Development Platform Sales Value Share by Application (2027-2032) Table 30. Global Precision Medicine Research and Development Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Precision Medicine Research and Development Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Precision Medicine Research and Development Platform Sales Value Share by Region (2021-2026) Table 33. Global Precision Medicine Research and Development Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Precision Medicine Research and Development Platform Sales Value Share by Region (2027-2032) Table 35. Global Precision Medicine Research and Development Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Precision Medicine Research and Development Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Precision Medicine Research and Development Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Precision Medicine Research and Development Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Precision Medicine Research and Development Platform Sales Value Market Share by Country (2027-2032) Table 40. Engine Biosciences Company Information Table 41. Engine Biosciences Business Overview Table 42. Engine Biosciences Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Engine Biosciences Precision Medicine Research and Development Platform Product Portfolio Table 44. Engine Biosciences Recent Development Table 45. Illumina Company Information Table 46. Illumina Business Overview Table 47. Illumina Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Illumina Precision Medicine Research and Development Platform Product Portfolio Table 49. Illumina Recent Development Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Thermo Fisher Scientific Precision Medicine Research and Development Platform Product Portfolio Table 54. Thermo Fisher Scientific Recent Development Table 55. Qiagen Company Information Table 56. Qiagen Business Overview Table 57. Qiagen Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Qiagen Precision Medicine Research and Development Platform Product Portfolio Table 59. Qiagen Recent Development Table 60. Personalis Company Information Table 61. Personalis Business Overview Table 62. Personalis Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Personalis Precision Medicine Research and Development Platform Product Portfolio Table 64. Personalis Recent Development Table 65. 23andMe Company Information Table 66. 23andMe Business Overview Table 67. 23andMe Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. 23andMe Precision Medicine Research and Development Platform Product Portfolio Table 69. 23andMe Recent Development Table 70. Foundation Medicine Company Information Table 71. Foundation Medicine Business Overview Table 72. Foundation Medicine Precision Medicine Research and Development Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Foundation Medicine Precision Medicine Research and Development Platform Product Portfolio Table 74. Foundation Medicine Recent Development Table 75. Research Programs/Design for This Report Table 76. Authors List of This Report Table 77. Secondary Sources Table 78. Primary Sources List of Figures Figure 1. Precision Medicine Research and Development Platform Product Image Figure 2. Global Precision Medicine Research and Development Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Precision Medicine Research and Development Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Precision Medicine Research and Development Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Genomics Platform Image Figure 8. Proteomics Platform Image Figure 9. Transcriptomics Platform Image Figure 10. Others Image Figure 11. Global Precision Medicine Research and Development Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Precision Medicine Research and Development Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Precision Medicine Research and Development Platform Sales Value Share by Type (2021-2032) Figure 14. Personalized Medicine Image Figure 15. Drug Discovery Image Figure 16. Global Precision Medicine Research and Development Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Precision Medicine Research and Development Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Precision Medicine Research and Development Platform Sales Value Share by Application (2021-2032) Figure 19. Global Precision Medicine Research and Development Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Precision Medicine Research and Development Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Precision Medicine Research and Development Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Precision Medicine Research and Development Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Precision Medicine Research and Development Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Precision Medicine Research and Development Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Precision Medicine Research and Development Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Precision Medicine Research and Development Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Precision Medicine Research and Development Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Precision Medicine Research and Development Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Precision Medicine Research and Development Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Precision Medicine Research and Development Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Genomics Platform
  • Proteomics Platform
  • Transcriptomics Platform
  • Others
Applications
  • Personalized Medicine
  • Drug Discovery
Companies covered
  • Engine Biosciences
  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Personalis
  • 23andMe
  • Foundation Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Precision Medicine Research and Development Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Precision Medicine Research and Development Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Precision Medicine Research and Development Platform Market Dynamics
  1. 2.1 Precision Medicine Research and Development Platform Industry Trends
  2. 2.2 Precision Medicine Research and Development Platform Industry Drivers
  3. 2.3 Precision Medicine Research and Development Platform Industry Opportunities and Challenges
  4. 2.4 Precision Medicine Research and Development Platform Industry Restraints
3 Precision Medicine Research and Development Platform Market by Company
  1. 3.1 Global Precision Medicine Research and Development Platform Company Revenue Ranking in 2025
  2. 3.2 Global Precision Medicine Research and Development Platform Revenue by Company (2021-2026)
  3. 3.3 Global Precision Medicine Research and Development Platform Company Ranking (2024-2026)
  4. 3.4 Global Precision Medicine Research and Development Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Precision Medicine Research and Development Platform Company Product Type and Application
  6. 3.6 Global Precision Medicine Research and Development Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Precision Medicine Research and Development Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Precision Medicine Research and Development Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Precision Medicine Research and Development Platform Market by Type
  1. 4.1 Precision Medicine Research and Development Platform Type Introduction
  2. 4.1.1 Genomics Platform
  3. 4.1.2 Proteomics Platform
  4. 4.1.3 Transcriptomics Platform
  5. 4.1.4 Others
  6. 4.2 Global Precision Medicine Research and Development Platform Sales Value by Type
  7. 4.2.1 Global Precision Medicine Research and Development Platform Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Precision Medicine Research and Development Platform Sales Value by Type (2021-2032)
  9. 4.2.3 Global Precision Medicine Research and Development Platform Sales Value Share by Type (2021-2032)
5 Precision Medicine Research and Development Platform Market by Application
  1. 5.1 Precision Medicine Research and Development Platform Application Introduction
  2. 5.1.1 Personalized Medicine
  3. 5.1.2 Drug Discovery
  4. 5.2 Global Precision Medicine Research and Development Platform Sales Value by Application
  5. 5.2.1 Global Precision Medicine Research and Development Platform Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Precision Medicine Research and Development Platform Sales Value by Application (2021-2032)
  7. 5.2.3 Global Precision Medicine Research and Development Platform Sales Value Share by Application (2021-2032)
6 Precision Medicine Research and Development Platform Regional Value Analysis
  1. 6.1 Global Precision Medicine Research and Development Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Precision Medicine Research and Development Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Precision Medicine Research and Development Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Precision Medicine Research and Development Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Precision Medicine Research and Development Platform Sales Value (2021-2032)
  7. 6.3.2 North America Precision Medicine Research and Development Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Precision Medicine Research and Development Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Precision Medicine Research and Development Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Precision Medicine Research and Development Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Precision Medicine Research and Development Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Precision Medicine Research and Development Platform Sales Value (2021-2032)
  16. 6.6.2 South America Precision Medicine Research and Development Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Precision Medicine Research and Development Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Precision Medicine Research and Development Platform Sales Value Share by Country, 2025 VS 2032
7 Precision Medicine Research and Development Platform Country-level Value Analysis
  1. 7.1 Global Precision Medicine Research and Development Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Precision Medicine Research and Development Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Precision Medicine Research and Development Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Precision Medicine Research and Development Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Precision Medicine Research and Development Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Precision Medicine Research and Development Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Precision Medicine Research and Development Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Engine Biosciences
  2. 8.1.1 Engine Biosciences Company Information
  3. 8.1.2 Engine Biosciences Business Overview
  4. 8.1.3 Engine Biosciences Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Engine Biosciences Precision Medicine Research and Development Platform Product Portfolio
  6. 8.1.5 Engine Biosciences Recent Developments
  7. 8.2 Illumina
  8. 8.2.1 Illumina Company Information
  9. 8.2.2 Illumina Business Overview
  10. 8.2.3 Illumina Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Illumina Precision Medicine Research and Development Platform Product Portfolio
  12. 8.2.5 Illumina Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Precision Medicine Research and Development Platform Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Qiagen
  20. 8.4.1 Qiagen Company Information
  21. 8.4.2 Qiagen Business Overview
  22. 8.4.3 Qiagen Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qiagen Precision Medicine Research and Development Platform Product Portfolio
  24. 8.4.5 Qiagen Recent Developments
  25. 8.5 Personalis
  26. 8.5.1 Personalis Company Information
  27. 8.5.2 Personalis Business Overview
  28. 8.5.3 Personalis Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Personalis Precision Medicine Research and Development Platform Product Portfolio
  30. 8.5.5 Personalis Recent Developments
  31. 8.6 23andMe
  32. 8.6.1 23andMe Company Information
  33. 8.6.2 23andMe Business Overview
  34. 8.6.3 23andMe Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 23andMe Precision Medicine Research and Development Platform Product Portfolio
  36. 8.6.5 23andMe Recent Developments
  37. 8.7 Foundation Medicine
  38. 8.7.1 Foundation Medicine Company Information
  39. 8.7.2 Foundation Medicine Business Overview
  40. 8.7.3 Foundation Medicine Precision Medicine Research and Development Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Foundation Medicine Precision Medicine Research and Development Platform Product Portfolio
  42. 8.7.5 Foundation Medicine Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst